EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is achieve standardization treatment of low and intermediate risk
rhabdomyosarcoma patients, with an attempt to improve treatment results in high and very high
risk patients by the addition of doxorubicin as induction treatment and at the maintenance
phase.